Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2021

View Archived Issues

LY-487379 shows synergistic effect on low-dose L-DOPA in a marmoset model

SB-0107 shows antiparkinsonian activity in animal models

Researchers establish N. gonorrhoeae upper reproductive tract infection model

Perampanel ameliorates development of alpha-syn pathology in models of PD

Japan Tobacco describes new PDHK2 inhibitors

Kallyope presents new free fatty acid FFA1 receptor agonists

Servier discovers nuclear factor erythroid 2-related factor 2 activators

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Potent inhibitor of sAC shows potential as nonhormonal contraceptive

Ventus outlines NLRP3 inhibitor program

Second Genome collaborates with VCU to generate biomarker for NASH with advanced fibrosis

Discovery of novel EP3 receptor antagonists

Chimeric spike mRNA-LNP vaccines show cross-protection against Sarbecovirus strains in vivo

Improved method of oligonucleotide synthesis using a novel P(V) platform

Avicanna's novel cannabinoid formulation shows promising preclinical results for epilepsy

Neddylation inhibition identified as a means of treating malignant rhabdoid tumors

Boan reports preclinical research data on CEA/CD3 bispecific antibody BA-1202

Infection derails healing after brain injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...